CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

NRIXNurix Therapeutics, Inc.

NASDAQ · Pharmaceutical Preparations
Last close $23.71 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$2.46B
RECENT INSIDER TRADES
  • 2026-10-02 · Ring Christine (Chief Legal Officer) · SELL
  • 2026-10-02 · Ring Christine (Chief Legal Officer) · OTHER
  • 2026-09-02 · Ring Christine (Chief Legal Officer) · SELL
  • 2026-09-02 · Ring Christine (Chief Legal Officer) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders224
Shares held131,460,651
Value$2.97B
Percent of shares outstanding126.67%
As of quarter end2026-06-30
RECENT NEWS
  • Nurix Therapeutics Announces First Patient Enrolled in Phase 1b/2 Combination Study of Bexobrutideg in Chronic Lymphocytic Leukemia
  • Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences
  • Nurix Therapeutics Announces Achievement of $7 Million Milestone Under Strategic Collaboration with Pfizer
  • Nurix Therapeutics presents at H.C. Wainwright investment conference
  • Nurix Therapeutics presents at Morgan Stanley healthcare conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Nurix Therapeutics, Inc. (NRIX) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit